U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455825) titled 'A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years' on March 03.
Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK), safety and tolerability of different oral formulations of AZD5004, and to evaluate the effect of food on these formulations in healthy participants.
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD5004
AZD5004 will be administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Service...